Episode Thumbnail
Episode 30  |  35:48 min

Understanding the New FDA Guidance on Changes to 510(k)

Episode 30  |  35:48 min  |  11.07.2019

Understanding the New FDA Guidance on Changes to 510(k)

00:00
00:00
This is a podcast episode titled, Understanding the New FDA Guidance on Changes to 510(k). The summary for this episode is: What happens you need to make a change to a device that’s been cleared via 510(k)? We discuss the importance of decision making during this process and relevant guidance from the FDA. The FDA just released updated guidelines on procedures regarding changes to 501(k) devices and software. Such changes in design or manufacturing are very common in the industry, so it’s important to understand the regulations as it pertains to your device. Our guest today is Mike Drues, president of Vascular Sciences and international regulatory affairs consultant. He works with governmental agencies and medical device companies around the world. Some of the topics discussed today include: - New FDA guidance on changes to 501(k) devices and software - Difference between FDA draft and final guidance - Keeping track of changes to medical devices in a “letter to file” - Limitations to FDA guidance flowcharts - Ways to notify the FDA of a change - Multiple changes made to an existing medical device - Going above and beyond to introduce quality controls for device changes
What happens you need to make a change to a device that’s been cleared via 510(k)? We discuss the importance of decision making during this process and relevant guidance from the FDA. The FDA just released updated guidelines on procedures regarding changes to 501(k) devices and software. Such changes in design or manufacturing are very common in the industry, so it’s important to understand the regulations as it pertains to your device. Our guest today is Mike Drues, president of Vascular Sciences and international regulatory affairs consultant. He works with governmental agencies and medical device companies around the world. Some of the topics discussed today include: - New FDA guidance on changes to 501(k) devices and software - Difference between FDA draft and final guidance - Keeping track of changes to medical devices in a “letter to file” - Limitations to FDA guidance flowcharts - Ways to notify the FDA of a change - Multiple changes made to an existing medical device - Going above and beyond to introduce quality controls for device changes

More Episodes

Focusing on the Intent of the UDI Requirements from FDA's Final Guidance Doc

Addressing the 'Who, What, When' of Quality in the Medical Device Industry

Meet a Guru: Maryann Mitchell

Why Storytelling Matters for Medical Device Companies

A Breakthrough Device that Aims to Prevent Osteoporosis

Understanding FDA's New Intended Use Rule and its Implications